Literature DB >> 21505927

[Value of different strategies in the treatment of vestibular schwannoma: therapeutic aspects and literature analysis].

W Maier1, T D Grauvogel, R Laszig, G J Ridder.   

Abstract

Treatment strategies for vestibular schwannoma have been extended and become more differentiated. An analysis of the international literature with the help of a PubMed search shows that otological and neurosurgical procedures as well as radiation therapies do not only compete but also complement each other. Standardized protocols for the classification of hearing, facial nerve function and quality of life enable a better comparison of functional results. Recent publications discuss - in addition to the standard of preserving facial nerve function and hearing - aspects of vestibular function as well as quality of life, especially in long-term follow up. In addition to effective tumour control, major focus is put on minimizing morbidity. The choice of therapy in patients with neurofibromatosis 2 and recurrent tumours is particularly challenging. The complex topic requires a profound knowledge of differential therapeutic aspects from consulting and treating physicians. Therefore, the individual treatment recommendation should be given in a specialized center.

Entities:  

Mesh:

Year:  2011        PMID: 21505927     DOI: 10.1007/s00106-011-2302-3

Source DB:  PubMed          Journal:  HNO        ISSN: 0017-6192            Impact factor:   1.284


  78 in total

1.  [Acoustic neuroma (vestibular schwannoma). Treatment from a neurosurgical perspective].

Authors:  U Schick; A Unterberg
Journal:  HNO       Date:  2011-01       Impact factor: 1.284

2.  Malignant peripheral nerve sheath tumor arising from benign vestibular schwannoma treated by gamma knife radiosurgery after two previous surgeries: a case report with surgical and pathological observations.

Authors:  Yosuke Akamatsu; Kensuke Murakami; Mika Watanabe; Hidefumi Jokura; Teiji Tominaga
Journal:  World Neurosurg       Date:  2010-06       Impact factor: 2.104

3.  Quality of life among acoustic neuroma patients managed by microsurgery, radiation, or observation.

Authors:  Joanne E Brooker; Jane M Fletcher; Michael J Dally; Robert J S Briggs; Vincent C Cousins; Robert I Smee; Gregory M Malham; Richard J Kennedy; Sue Burney
Journal:  Otol Neurotol       Date:  2010-08       Impact factor: 2.311

4.  Vestibular schwannomas: clinical results and quality of life after microsurgery or gamma knife radiosurgery.

Authors:  Erling Myrseth; Per Møller; Paal-Henning Pedersen; Flemming S Vassbotn; Tore Wentzel-Larsen; Morten Lund-Johansen
Journal:  Neurosurgery       Date:  2005-05       Impact factor: 4.654

5.  Fractionated stereotactic radiotherapy for acoustic neuroma: single-institution experience at The Princess Margaret Hospital.

Authors:  Eng-Siew Koh; Barbara-Ann Millar; Cynthia Ménard; Howard Michaels; Mostafa Heydarian; Shenaz Ladak; Sharon McKinnon; John A Rutka; Abhijit Guha; Gregory R Pond; Normand J Laperriere
Journal:  Cancer       Date:  2007-03-15       Impact factor: 6.860

Review 6.  Dose reduction improves hearing preservation rates after intracanalicular acoustic tumor radiosurgery.

Authors:  A Niranjan; L D Lunsford; J C Flickinger; A Maitz; D Kondziolka
Journal:  Neurosurgery       Date:  1999-10       Impact factor: 4.654

7.  [Subtemporal approach according to house versus Wigand in intrameatal CPA tumors type A].

Authors:  J Schipper; W Maier; R Laszig
Journal:  Laryngorhinootologie       Date:  2004-10       Impact factor: 1.057

8.  Technical modifications to the middle fossa craniotomy approach in removal of acoustic neuromas.

Authors:  D E Brackmann; J R House; W E Hitselberger
Journal:  Am J Otol       Date:  1994-09

9.  [Removal of acoustic neuromas of the cerebellopontile angle with transtemporal approach by the middle cranial fossa].

Authors:  M E Wigand; G Rettinger; T Haid; M Berg
Journal:  HNO       Date:  1985-01       Impact factor: 1.284

10.  Irradiation of cochlear structures during vestibular schwannoma radiosurgery and associated hearing outcome.

Authors:  Nicolas Massager; Ouzi Nissim; Carine Delbrouck; Isabelle Delpierre; Daniel Devriendt; Françoise Desmedt; David Wikler; Jacques Brotchi; Marc Levivier
Journal:  J Neurosurg       Date:  2007-10       Impact factor: 5.115

View more
  4 in total

1.  Outcome on hearing and facial nerve function in microsurgical treatment of small vestibular schwannoma via the middle cranial fossa approach.

Authors:  Christian Ginzkey; Matthias Scheich; Wilma Harnisch; Verena Bonn; Desiree Ehrmann-Müller; Wafaa Shehata-Dieler; Robert Mlynski; Rudolf Hagen
Journal:  Eur Arch Otorhinolaryngol       Date:  2012-06-22       Impact factor: 2.503

2.  Stereotactic radiotherapy of vestibular schwannoma : Hearing preservation, vestibular function, and local control following primary and salvage radiotherapy.

Authors:  Florian Putz; Jan Müller; Caterina Wimmer; Nicole Goerig; Stefan Knippen; Heinrich Iro; Philipp Grundtner; Ilker Eyüpoglu; Karl Rössler; Sabine Semrau; Rainer Fietkau; Sebastian Lettmaier
Journal:  Strahlenther Onkol       Date:  2016-12-07       Impact factor: 3.621

3.  [Vestibular schwannoma. Part 2: therapy, prognosis, and rehabilitation].

Authors:  W Maier; F Hassepaß; A Aschendorff; R Laszig
Journal:  HNO       Date:  2012-10       Impact factor: 1.284

4.  Clinical outcome of neurofibromatosis type 2-related vestibular schwannoma: treatment strategies and challenges.

Authors:  Byung Sup Kim; Ho Jun Seol; Jung-Il Lee; Hyung Jin Shin; Kwan Park; Doo-Sik Kong; Do-Hyun Nam; Yang-Sun Cho
Journal:  Neurosurg Rev       Date:  2016-05-04       Impact factor: 3.042

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.